Smoking cessation interventions for smokers with current or past depression (Q24200330)

4

0 references

author name string

Regina M van der Meer

1

0 references

Marc C Willemsen

2

0 references

Filip Smit

Cochrane Database of Systematic Reviews

3

0 references

publication date

21 August 2013

0 references

published in

0 references

cites work

A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Development and validation of a cluster-based classification system to facilitate treatment tailoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Bupropion and cognitive-behavioral treatment for depression in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Hypnosis for smoking cessation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A randomized trial of targeted educational materials for smoking cessation in African Americans using transdermal nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effects of an intensive depression-focused intervention for smoking cessation in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A randomized trial of sertraline as a cessation aid for smokers with a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A tailored smoking, alcohol, and depression intervention for head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Development of major depression after treatment for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Psychological intervention and antidepressant treatment in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Extended treatment of older cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Home health care nurses as a new channel for smoking cessation treatment: outcomes from project CARES (Community-nurse Assisted Research and Education on Smoking).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The influence of quality of life and depressed mood on smoking cessation among medically ill smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Dimensions of depressive symptoms and smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Onset of major depression during treatment for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Nicotine patch and paroxetine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Extended cognitive behavior therapy for cigarette smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effects of nicotine gum dose by level of nicotine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Timing of alcohol and smoking cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The impact of depressive symptoms on alcohol and cigarette consumption following treatment for alcohol and nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A history of depression and smoking cessation outcomes among women concerned about post-cessation weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Bupropion and cognitive behavioral therapy for weight-concerned women smokers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Telephone assistance for smoking cessation: one year cost effectiveness estimations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Integrating smoking cessation into mental health care for post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Automated e-mail messaging as a tool for improving quit rates in an internet smoking cessation intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Design and pilot evaluation of an internet smoking cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Toward evidence-based Internet interventions: A Spanish/English Web site for international smoking cessation trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effects of frequency and duration in telephone counselling for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

American Cancer Society's QuitLink: randomized trial of Internet assistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Comparing internet assistance for smoking cessation: 13-month follow-up of a six-arm randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Randomized controlled trial of an interactive internet smoking cessation program with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A bupropion smoking cessation clinical trial for cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Targeting smokers at increased risk for relapse: treating women and those with a history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking outcome by psychiatric history after behavioral and varenicline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Behavioral counseling and varenicline treatment for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Bupropion for smokers hospitalized with acute cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effectiveness of a mood management component as an adjunct to a telephone counselling smoking cessation intervention for smokers with a past major depression: a pragmatic randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Feasibility of an exercise counseling intervention for depressed women smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Differences in smoking expectancies in smokers with and without a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effectiveness of a nurse-managed, lay-led tobacco cessation intervention among ohio appalachian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Efficacy of an alternative smoking cessation treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Physical activity as a protective factor in relapse following smoking cessation in participants with a depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Mindfulness training for smoking cessation: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effect of a nicotine-free inhalator as part of a smoking-cessation programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Differential effects of depression on smoking cessation in a diverse sample of smokers in treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Varenicline and bupropion sustained-release combination therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking cessation and relapse among pregnant African-American smokers in Washington, DC

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Major depression following smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effectiveness of varenicline for smoking cessation: a 1-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Depression vulnerability moderates the effects of cognitive behavior therapy in a randomized controlled trial for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Changes in lifestyle for psychiatric patients three years after the start of short- and long-term psychodynamic psychotherapy and solution-focused therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Naltrexone and nicotine patch smoking cessation: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effect of bupropion on depression symptoms in a smoking cessation clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Feasibility and acceptability of a multiple risk factor intervention: the Step Up randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression ('MoodCare'): study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Mediators of the association of major depressive syndrome and anxiety syndrome with postpartum smoking relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Preventing postpartum smoking relapse among diverse low-income women: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Mood management intervention for college smokers with elevated depressive symptoms: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking cessation treatment in community-based substance abuse rehabilitation programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effect of cognitive behavior therapy on smokers' compensatory coping skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Depression and smoking in a smoking cessation programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Acute effects of moderate intensity aerobic exercise on affective withdrawal symptoms and cravings among women smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Moderate intensity exercise as an adjunct to standard smoking cessation treatment for women: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Association of smoking status, cumulative smoking, duration of smoking cessation, age of starting smoking, and depression in Korean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Yoga as a complementary treatment for smoking cessation in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Motivating parents of kids with asthma to quit smoking: the PAQS project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: the importance of tracking idiographic change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Intensive intervention for alcohol-dependent smokers in early recovery: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Expectancies regarding the interaction between smoking and substance use in alcohol-dependent smokers in early recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Assessment of depression among African American light smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Bupropion for smoking cessation in African American light smokers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Associations of mindfulness with nicotine dependence, withdrawal, and agency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Associations between mindfulness and implicit cognition and self-reported affect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Placebo-controlled trial of cytisine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Group hypnotherapy versus group relaxation for smoking cessation: an RCT study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Anxiety sensitivity and cognitive-based smoking processes: testing the mediating role of emotion dysregulation among treatment-seeking daily smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking cessation: next steps for special populations research and innovative treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Major depression and stages of smoking. A longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Cigarette smoking, major depression, and other psychiatric disorders among adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Tobacco cessation among patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Major depression and cigarette smoking: results of a 21-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking cessation interventions for patients with depression: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Cigarette smoking: implications for psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Nicotine interventions with comorbid populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Treatment of tobacco dependence in mental health and addictive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The need for dissemination of evidence-based results from research on nicotine and tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Antidepressants for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Co-morbidity of smoking in patients with psychiatric and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking and major depression. A causal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Individual behavioural counselling for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Proactive telephone counseling as an adjunct to minimal intervention for smoking cessation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Systematic review: smoking cessation intervention strategies for adults and adults in special populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Assessing motivation to quit smoking in people with mental illness: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Telephone counselling for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

Smoking and mental illness: A population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Depression and depressive symptoms in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Transdermal nicotine for smoking cessation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Smoking cessation and the course of major depression: a follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Depression and smoking cessation: the role of motivation and self-efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Nicotine gum dose and weight gain after smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Cognitive-behavioral treatment for depression in smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Fluoxetine, smoking, and history of major depression: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Effect of history of alcoholism or major depression on smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Naltrexone effects on short-term and long-term smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006102.PUB2

7 January 2021

10.1002/14651858.CD006102.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4474886

OpenCitations bibliographic resource ID

4474886

1 reference